Older patients with inflammatory bowel disease who initiate Entyvio therapy had lower risk for hospitalization than those treated with anti-TNF, according to research presented at the Crohn’s and Colitis Congress.

Bharati Kochar, MD, from Massachusetts General Hospital, said that while older adults make up a large portion of patients with IBD in the United States, they are not well represented in clinical trials.

“While more than a quarter of Americans with IBD are older than 65, less than 1% of adults in clinical trials of approved IBD therapies are 65 years or older,” she

Full Article: https://www.healio.com/news/gastroenterology/20210124/hospitalizations-less-likely-among-older-patients-with-ibd-on-entyvio